Drugs / TDS-943
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00546507 | Oct 2007 → Oct 2008 | osteoarthritis | Mika Pharma GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDS-943 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00546507 ↗ |
| Known as | diclofenac sodium | “TDS-943 (topical diclofenac sodium 4% spray)” NCT00546507 ↗ |
| Route | Topical | “TDS-943 40 mg bid topically” NCT00546507 ↗ |